$SBFM UPDATE -- Sunshine Biopharma Launches eCommerce Store

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
81
$SBFM UPDATE -- Sunshine Biopharma Launches eCommerce Store for Its Science-Based Nutritional Supplements

MONTREAL, March 01, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a leader in nutrition research and development today unveiled its new eCommerce website, Nutrition.SunshineBiopharma.com. The site boasts over 20 products ranging from essential amino acids and rich protein powders to balanced vitamins and crucial micronutrients. All of Sunshine Biopharma’s nutritional supplements are manufactured and tested in Canada under strict GMP conditions and Health Canada oversight. Some of the products listed on Nutrition.Sunshinebiopharma.com will continue to be available on Amazon.com and Amazon.ca.

Seekers of the highest quality, science-based nutritional products will enjoy the Nutrition.SunshineBiopharma.com experience where they can easily browse the items listed, place their order and checkout in a streamlined manner. Among the products featured on Nutrition.SunshineBiopharma.com is Essential 9™, a tablet containing all 9 essential amino acids that the human body cannot produce on its own. Essential 9™ was developed and formulated by Sunshine Biopharma, a pharmaceutical company that has the user’s optimum health in mind. Now more than ever, it is critical to maintain optimal health amidst the global pandemic. Among its many benefits, Essential 9™ can help boost the immune system and increase overall health. In addition to Essential 9™, Nutrition.SunshineBiopharma.com offers other health promoting supplements including balanced vitamins, individual amino acids, protein, and meal replacement products.

"In 2020, eCommerce sales in the US amounted to approximately $374 billion and are expected to reach $476 billion by 2024. We are thrilled to introduce Nutrition.Sunshinebiopharma.com, which allows customers to shop reliable, routinely tested nutritional supplements anytime," said Camille Sebaaly, CFO of Sunshine Biopharma. "Our site will feature a unique assortment of the nutritional products valued by everyone. We are excited for customers to enjoy our fun, interactive features and curations."

About Essential 9™

Essential Amino Acids are 9 out of the 20 amino acids required for protein synthesis. Proteins are involved in all body functions – From the musculature and immune system to hormones and neurotransmitters. Like vitamins, Essential Amino Acids cannot be made by the human body and must be obtained through diet. Deficiency in one or more of the 9 Essential Amino Acids can lead to loss of muscle mass, chronic fatigue, weight gain, and weakened immune system. Sunshine Biopharma’s Essential-9™ provides a balanced formula of all 9 Essential Amino Acids in free-form, ready to be absorbed. Essential-9™ is suitable for everyone: Vegans, Seniors, Dieters, Athletes, and everyone looking to increase their health.

Safe Harbor Forward-Looking Statements

This press release may contain forward-looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to general stock market conditions. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC filings. We have incurred and will continue to incur significant expenses in our expansion of our existing as well as new service lines noting there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. Additional service offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the various geopolitical locations we will be providing services in, the impact of which cannot be predicted at this time.

For Additional Information Contact:
Camille Sebaaly, CFO
Sunshine Biopharma Inc.
Direct Line: 514-814-0464
camille.sebaaly@sunshinebiopharma.com
http://www.sunshinebiopharma.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Capacity LLC: Finalist in 2026 BeautyMatter Awards

Updated Category News Views 111

A Nod to Logistics and Beauty When beauty meets logistics, you end up with something like Capacity LLC making headlines in the 2026 BeautyMatter Awards. Now, I ain't one to usually get excited about anything involving freight and boxes, but this isn't just any nod in the 'Best Logistics Solution' category; it speaks volumes about where the beauty business is heading. Why...

Continue Reading
Piramal Pharma FY27 Q2 Results: Robust Growth & Optimism

Updated Category News Views 38

A Solid Performance from Piramal Pharma The numbers are in, and it's looking pretty good for Piramal Pharma Limited this time around. Their second quarter of fiscal year 2027 has seen some fireworks, and I'm not talking about some half-baked confetti deal. We're talking genuine growth and solid metrics here. Revenue and Profit Surge The headline? Revenue jumped a whopping...

Continue Reading
Kimberly-Clark Extends Kenvue Notes Exchange Deadline

Updated Category News Views 72

Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...

Continue Reading
DICK'S Sporting Goods Faces Investor Lawsuit Deadline Looms

Updated Category News Views 23

A Rough Tumble for DICK'S Sporting Goods Let's cut to the chase: DICK'S Sporting Goods, Inc. (NYSE:DKS) just took a nosedive. We're talking a hard 30.68% fall on the stock, plummeting to $124.31 a share as of August 25, 2026. Now, if you were caught up in this whirlwind as an investor, you'd be forgiven for having a few choice words for the powers that be over at DICK'S....

Continue Reading
Political Jitters Push US Investors to Golden Visas

Updated Category News Views 118

Judging by the latest buzz from La Vida's 2026 survey, the golden ticket for many US investors isn't a hot stock but something far more unexpected: the coveted 'Golden Visa.' Out of over 5,000 wealthy individuals invited to participate, 94.3% are mulling over a second residency or citizenship, and the big trigger? Political concerns. It's a clear sign that plenty of...

Continue Reading
GeneDx Faces Scrutiny: Are Fiduciary Duties at Risk?

Updated Category News Views 71

What's Brewing at GeneDx? Looks like GeneDx Holdings Corp. is in some hot water—at least that's what Halper Sadeh LLC seems to think. Not your regular Tuesday at the exchange, folks. This legal eagle outfit is poking around GeneDx's henhouse, signaling possible breaches of fiduciary duties by their officers and directors. It's like catching a whiff of something fishy...

Continue Reading
BNY's Conference Spotlight: Strategic Moves Ahead?

Updated Category News Views 119

BNY's CFO to Unpack Strategies at BMO Financials Conference They say you can tell a lot about a company by the folks steering the ship. And let me tell you, folks, Dermot McDonogh from BNY is setting sail over to Boca Raton to spill some beans. November 9 marks the date when BNY’s Chief Financial Officer will stand behind the mic at the BMO Financials Conference at 8:45...

Continue Reading
CELSET Unveils SOLTOX: Expanding in Global Markets

Updated Category News Views 9

New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...

Continue Reading
Jennifer Sharp Bolsters Signature Wealth's Greenville Team

Updated Category News Views 88

New Beginnings with Signature Wealth There's a fresh breeze blowing through Signature Wealth's Greenville office, and its name is Jennifer Sharp. Now, if you're meandering through financial landscapes, Sharp is the guide you didn’t know you needed—until now. With nearly 20 years under her belt, she brings a wealth of experience coupled with a knack for handling life's...

Continue Reading
Photocure's Q3 2026: Revenue Plateau and CFO Shakeup

Updated Category News Views 7

The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...

Continue Reading

Top 5 Most Recently Viewed Articles

Nutriband Inc.'s Highlight at 2024 Noble Conference in Boca Raton

Updated Category News Views 96

Nutriband Inc. to Showcase Innovations at Noble Conference Nutriband Inc. is set to make a significant impact at the upcoming Noble Conference, which takes place at Florida Atlantic University. The event is scheduled for early December, where the company will highlight its advancements in transdermal pharmaceutical products. Key Presentation Details At the Noble...

Continue Reading
ADT Inc. Plans Significant Financial Results Announcement

Updated Category News Views 123

ADT Inc.'s Financial Results Release ADT Inc. is preparing to unveil its second quarter financial results soon. While the specific date of this event is not mentioned here, it’s highly anticipated within the financial community. Prior to the market opening, ADT will share details on its performance at this key time for the company. Conference Call and Webcast Details...

Continue Reading
ProcessUnity's Vision for Transforming Risk Management by 2025

Updated Category News Views 594

Transforming Third-Party Risk Management: ProcessUnity's Ambitious Goals As an industry leader in third-party risk management, ProcessUnity has made significant strides over the past year, showcasing impressive growth and innovation. With a firm commitment to addressing modern security challenges, the company plans to revolutionize the TPRM landscape in 2025. This...

Continue Reading
Harnessing AI for Materials Discovery Amid Computing Challenges

Updated Category News Views 125

AI's Impact on Materials Discovery In today's swiftly evolving technological landscape, advancements in AI are making a significant impact on various fields, particularly in materials science. The integration of AI in materials research aims to accelerate the discovery process and improve efficiency, enabling researchers to bring innovative solutions to the forefront....

Continue Reading
Exploring the Growth and Impact of IVR Software Solutions

Updated Category News Views 123

Overview of Interactive Voice Response (IVR) Software Market The Global Interactive Voice Response (IVR) Software market is anticipated to witness significant growth in the coming years. Projections indicate an increase from USD 4,596.5 million in the near future to USD 6,124.6 million by the end of the forecast period, reflecting an impressive Compound Annual Growth Rate...

Continue Reading